Shareholder Alert: The Ademi Firm investigates whether Select Medical Holdings Corporation is obtaining a Fair Price for its Public Shareholders

Group 1 - Ademi LLP is investigating Select Medical Holdings Corporation for potential breaches of fiduciary duty and other legal violations related to a transaction with a consortium led by Executive Chairman Robert A. Ortenzio and private equity firm Welsh, Carson, Anderson & Stowe [1] - The transaction involves Select Medical stockholders receiving $16.50 per share in cash, with an enterprise value of approximately $3.9 billion [1] - The transaction agreement imposes significant penalties on Select Medical for accepting competing bids, raising concerns about the board's fulfillment of fiduciary duties to all shareholders [1]